Beginning with the EMPA-REG OUTCOME trial in 2015, multiple glucose-lowering therapies have demonstrated a reduction in cardiovascular outcomes in people both with and without T2D
The dose increase (or decrease) can only be performed under the healthcare providers supervision, which is a common recommendation among all approved weight loss medications
If you're not a member, you can download an excerpt of that work above, or reach out to us to learn more.
Although drugmakers have cut prices for cash-paying customers, more than half of adults on GLP-1s say the drugs have been difficult to afford, according to KFF, a health policy nonprofit
Retatrutide represents the current frontier of what is pharmacologically possibleits weight loss numbers are, objectively, historic
Mistake 2: Injecting Too Quickly Rapidly injecting the entire solution causes pain, bruising, and possible tissue irritation